Impact Biomedical Inc. 2024 Investor Presentation

Impact Biomedical Inc. (IBIO) is a biomedical company discovering and developing healthcare innovations across consumer wellness, biopharmaceuticals, and medical technology platforms. The company holds eight issued patents and 40+ pending patents, with a portfolio including anti-viral treatments, natural insect repellents, biopharmaceuticals for inflammatory and oncology applications, and bioplastics. IBIO plans a $5-10MM IPO to fund R&D, acquisitions, and strategic partnerships.